(January 2, 2019, 4:09 PM EST) -- PHILADELPHIA — The Third Circuit U.S. Court of Appeals on Dec. 28 affirmed dismissal of an Avandia heart attack case, agreeing with the multidistrict litigation court that the prescribing physician stopped short of saying he would not have prescribed the diabetes drugs if he had been more fully warned of its heart risks (In Re: Avandia Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 18-1059, 3rd Cir., 2018 U.S. App. LEXIS 36682)....